已发表论文

lncRNA RHPN1-AS1 通过抑制 miR-1299 促进卵巢癌的生长和侵袭

 

Authors Zhao L, Liu T, Zhang X, Zuo D, Liu C

Received 2 February 2020

Accepted for publication 1 May 2020

Published 10 June 2020 Volume 2020:13 Pages 5337—5344

DOI https://doi.org/10.2147/OTT.S248050

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Leo Jen-Liang Su

Background: Ovarian cancer (OC) is a big threat for public health. However, the molecular mechanism underlying OC development and progression remains unclear. Although the importance of lncRNA in cancer has been proven, how lncRNA is involved in OC is waiting for further investigation.
Materials and Methods: qRT-PCR was performed to test expression level. CCK8 and colony formation were conducted to analyze proliferation. Transwell was conducted to measure migration and invasion. Luciferase reporter assay and pulldown assay were utilized to validate RNA interaction.
Results: lncRNA RHPN1-AS1 was highly expressed in OC tissues. RHPN1-AS1 was positively correlated with OC progression and its high expression indicated a low survival rate. Moreover, knockdown of RHPN1-AS1 significantly inhibited the proliferation, migration and invasion of OC cells, and bioinformatics analysis identified that miR-1299 was sponged by RHPN1-AS1 in OC cells. Knockdown of RHPN1-AS1 markedly promoted miR-1299 expression. Of note, inhibition of miR-1299 reversed the roles of RHPN1-AS1 silencing on suppressing proliferation, migration and invasion.
Conclusion: Our study demonstrates that RHPN1-AS1 promotes OC progression via sponging miR-1299, suggesting RHPN1-AS1 may be a novel therapeutic target.
Keywords: ovarian cancer, RHPN1-AS1, miR-1299, proliferation, invasion




Figure 1 lncRNA RHPN1-AS1 was upregulated in OC tissues and...